Nome |
# |
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection, file e268c4c9-ab16-a6b7-e053-3a05fe0adea1
|
503
|
Management of KPC-producing Klebsiella pneumoniae infections, file e268c4c9-ec77-a6b7-e053-3a05fe0adea1
|
196
|
Impact of negative blood cultures on outcome after surgery for acute infective endocarditis, file e268c4c9-cb3a-a6b7-e053-3a05fe0adea1
|
151
|
Incidence and outcome of invasive candidiasis in intensive care units (icus) in europe: Results of the eucandicu project, file e268c4ca-8641-a6b7-e053-3a05fe0adea1
|
141
|
Treatment of Infections Due to MDR Gram-Negative Bacteria, file e268c4ca-6fc0-a6b7-e053-3a05fe0adea1
|
125
|
Epidemiology, management, and outcome of carbapenem-resistant Klebsiella pneumoniae bloodstream infections in hospitals within the same endemic metropolitan area, file e268c4c8-02d1-a6b7-e053-3a05fe0adea1
|
120
|
Antibiotic treatment of infections caused by carbapenem-resistant Gram-negative bacilli: an international ESCMID cross-sectional survey among infectious diseases specialists practicing in large hospitals, file e268c4ca-71a3-a6b7-e053-3a05fe0adea1
|
119
|
New insights into infections due to multidrug resistant gram negative bacteria: The interplay between lab and clinic, file e268c4ca-379b-a6b7-e053-3a05fe0adea1
|
117
|
Hypoalbuminemia as a predictor of acute kidney injury during colistin treatment, file e268c4ca-3d9a-a6b7-e053-3a05fe0adea1
|
111
|
Infections caused by KPC-producing Klebsiella pneumoniae: Differences in therapy and mortality in a multicentre study, file e268c4ca-4fb6-a6b7-e053-3a05fe0adea1
|
106
|
Pre-Engraftment Bloodstream Infections after Allogeneic Hematopoietic Cell Transplantation: Impact of T Cell-Replete Transplantation from a Haploidentical Donor, file e268c4cb-6bac-a6b7-e053-3a05fe0adea1
|
105
|
Risk factors for infections due to carbapenem-resistant Klebsiella pneumoniae after open heart surgery, file e268c4ca-66ad-a6b7-e053-3a05fe0adea1
|
91
|
Respiratory Fungal Diseases in Adult Patients With Cystic Fibrosis, file e268c4ca-1553-a6b7-e053-3a05fe0adea1
|
76
|
Use of colistin in adult patients: a cross-sectional study, file e268c4c9-d54c-a6b7-e053-3a05fe0adea1
|
71
|
Commentary: Human Immunodeficiency Virus and Allergic Bronchopulmonary Aspergillosis, file e268c4ca-5f46-a6b7-e053-3a05fe0adea1
|
70
|
Ceftobiprole: drug evaluation and place in therapy, file e268c4cb-6a79-a6b7-e053-3a05fe0adea1
|
67
|
Combined use of serum (1,3)-β-d-glucan and procalcitonin for the early differential diagnosis between candidaemia and bacteraemia in intensive care units, file e268c4ca-2c33-a6b7-e053-3a05fe0adea1
|
59
|
Efficacy and Safety of Meropenem–Vaborbactam Versus Best Available Therapy for the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections in Patients Without Prior Antimicrobial Failure: A Post Hoc Analysis, file e268c4ca-6fbe-a6b7-e053-3a05fe0adea1
|
54
|
Tedizolid phosphate for the treatment of acute bacterial skin and skin-structure infections: an evidence-based review of its place in therapy, file e268c4ca-64fc-a6b7-e053-3a05fe0adea1
|
53
|
Machine learning and multidrug-resistant gram-negative bacteria: An interesting combination for current and future research, file e268c4cc-1366-a6b7-e053-3a05fe0adea1
|
53
|
Reactivation of Herpes Simplex Virus Type 1 (HSV-1) Detected on Bronchoalveolar Lavage Fluid (BALF) Samples in Critically Ill COVID-19 Patients Undergoing Invasive Mechanical Ventilation: Preliminary Results from Two Italian Centers, file e268c4ce-f803-a6b7-e053-3a05fe0adea1
|
30
|
Valutazione dei fattori di rischio per lo sviluppo di candidemia dopo interventi di cardiochirurgia maggiore, file e268c4cc-173e-a6b7-e053-3a05fe0adea1
|
26
|
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy, file e268c4cc-c929-a6b7-e053-3a05fe0adea1
|
26
|
Use of ceftaroline in hospitalized patients with and without covid-19: A descriptive cross-sectional study, file e268c4cd-d181-a6b7-e053-3a05fe0adea1
|
24
|
Candida auris Candidemia in Critically Ill, Colonized Patients: Cumulative Incidence and Risk Factors, file e268c4ce-9d89-a6b7-e053-3a05fe0adea1
|
21
|
Early Detection of Sepsis With Machine Learning Techniques: A Brief Clinical Perspective, file e268c4cd-90dc-a6b7-e053-3a05fe0adea1
|
18
|
Mycobacterium tuberculosis Surgical Site Infection after Cardiac Surgery in the COVID-19 Era: A Case Report, file e268c4ce-8b18-a6b7-e053-3a05fe0adea1
|
13
|
Bronchoalveolar lavage fluid characteristics and outcomes of invasively mechanically ventilated patients with COVID-19 pneumonia in Genoa, Italy, file e268c4cd-f66b-a6b7-e053-3a05fe0adea1
|
11
|
The COVID-19 insidious trick: Subjective perception of numbers, file e268c4cd-7014-a6b7-e053-3a05fe0adea1
|
10
|
External validation of unsupervised COVID-19 clinical phenotypes and their prognostic impact, file 8667f211-1d12-4413-996c-d35c93fae18d
|
9
|
A NLP Pipeline for the Automatic Extraction of a Complete Microorganism’s Picture from Microbiological Notes, file ce351f22-b380-4ab1-ba35-ea05704f8270
|
9
|
Risk factors for infections due to carbapenem-resistant Klebsiella pneumoniae after cardiac surgery, file e268c4c9-9ea8-a6b7-e053-3a05fe0adea1
|
9
|
A Wide Database for a Multicenter Study on Pneumocystis jirovecii Pneumonia in Intensive Care Units, file 70fcd282-7e8f-41b0-8bd5-d9cea486654e
|
8
|
Valutazione dei fattori di rischio per lo sviluppo di candidemia dopo interventi di cardiochirurgia maggiore, file e268c4cc-18da-a6b7-e053-3a05fe0adea1
|
8
|
null, file e268c4cd-7625-a6b7-e053-3a05fe0adea1
|
8
|
A wide database for future studies aimed at improving early recognition of candidemia, file e268c4cf-0aa8-a6b7-e053-3a05fe0adea1
|
8
|
Validation of an Automated System for the Extraction of a Wide Dataset for Clinical Studies Aimed at Improving the Early Diagnosis of Candidemia, file eb013e88-73cb-4784-ad6c-2d656c026b83
|
8
|
Higher mortality and intensive care unit admissions in COVID-19 patients with liver enzyme elevations, file 8304aec2-8fd5-45d6-984d-d259fbfaa197
|
6
|
Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study, file e268c4cd-9637-a6b7-e053-3a05fe0adea1
|
6
|
Computed tomography assessment of PEEP-induced alveolar recruitment in patients with severe COVID-19 pneumonia, file e268c4cd-e328-a6b7-e053-3a05fe0adea1
|
6
|
Enterococcal bloodstream infections in critically ill patients with COVID-19: a case series, file e268c4ce-4fd3-a6b7-e053-3a05fe0adea1
|
6
|
Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy, file f2e2c9fe-0015-4107-81ef-fb915010dffd
|
6
|
Tracheostomy Timing and Outcome in Severe COVID-19: The WeanTrach Multicenter Study, file e268c4cd-ca2c-a6b7-e053-3a05fe0adea1
|
5
|
Intermediate monocytes expansion and homing markers expression in COVID-19 patients associate with kidney dysfunction, file 43574f6f-d70a-4cc6-8bb8-48d6d4579c95
|
4
|
Impact of a mixed educational and semi-restrictive antimicrobial stewardship project in a large teaching hospital in Northern Italy, file e268c4c8-07fc-a6b7-e053-3a05fe0adea1
|
4
|
Risk factors for candidemia after open-heart surgery: results from a multicenter case-control study, file e268c4cd-d6e3-a6b7-e053-3a05fe0adea1
|
4
|
Prevalence and prognostic value of cardiac troponin in elderly patients hospitalized for COVID-19, file e268c4cf-0177-a6b7-e053-3a05fe0adea1
|
4
|
Protocol of Validation Mechanisms Within the Design of an Electronic Case Report Form for the MULTI-SITA Project, file f91bc48c-fe10-416c-89f6-e7c6348e6501
|
4
|
Pneumocystis jirovecii pneumonia in intensive care units: a multicenter study by ESGCIP and EFISG, file 0140954a-79cd-45a4-887d-01b069b16f3d
|
3
|
Mortality in KPC-producing Klebsiella pneumoniae bloodstream infections: a changing landscape, file 8df8a16d-6a08-4aca-b419-c74b9ba70b07
|
3
|
Trends in the annual incidence of carbapenem-resistant Klebsiella pneumoniae bloodstream infections: A 8-year retrospective study in a large teaching hospital in northern Italy, file e268c4c6-aa5e-a6b7-e053-3a05fe0adea1
|
3
|
Previous bloodstream infections due to other pathogens as predictors of carbapenem-resistant Klebsiella pneumoniae bacteraemia in colonized patients: results from a retrospective multicentre study, file e268c4ca-57e8-a6b7-e053-3a05fe0adea1
|
3
|
Judging the appropriate therapy for carbapenem-resistant Acinetobacter infections, file e268c4cc-10d0-a6b7-e053-3a05fe0adea1
|
3
|
Tocilizumab and steroid treatment in patients with COVID-19 pneumonia, file e268c4cc-ab5a-a6b7-e053-3a05fe0adea1
|
3
|
Evaluating cefiderocol in the treatment of multidrug-resistant gram-negative bacilli: A review of the emerging data, file e268c4cd-4170-a6b7-e053-3a05fe0adea1
|
3
|
A look at the clinical, economic, and societal impact of antimicrobial resistance in 2020, file e268c4cd-55be-a6b7-e053-3a05fe0adea1
|
3
|
Treatment of Bloodstream Infections Due to Gram-Negative Bacteria with Difficult-to-Treat Resistance, file e268c4cd-7d25-a6b7-e053-3a05fe0adea1
|
3
|
Comorbidities, cardiovascular therapies, and COVID-19 mortality: A nationwide, italian observational study (ItaliCO), file e268c4cd-f822-a6b7-e053-3a05fe0adea1
|
3
|
Early versus late intubation in COVID-19 patients failing helmet CPAP: A quantitative computed tomography study, file e268c4ce-d07c-a6b7-e053-3a05fe0adea1
|
3
|
Recent advances and future perspectives in the pharmacological treatment of Candida auris infections, file 1fdb3499-d185-4dbc-b899-635980a5a3e3
|
2
|
Kidney disease and all-cause mortality in patients with COVID-19 hospitalized in Genoa, Northern Italy, file 289f0df2-993e-441f-8b16-3d0cac2a001d
|
2
|
Molecular Epidemiological Investigation of a Nosocomial Cluster of C. auris: Evidence of Recent Emergence in Italy and Ease of Transmission during the COVID-19 Pandemic, file 71147a29-e541-4cad-9112-5e2a1bcd6c46
|
2
|
Herpes Simplex Virus 1 (HSV-1) Reactivation in Critically Ill COVID-19 Patients: A Brief Narrative Review, file c9614277-f4bf-479c-9cdf-d74789b49180
|
2
|
Regional point prevalence study of healthcare-associated infections and antimicrobial use in acute care hospitals in Liguria, Italy, file e268c4c8-f92b-a6b7-e053-3a05fe0adea1
|
2
|
The diagnostic conundrum of bacterial infections in cirrhotic patients, file e268c4ca-18d6-a6b7-e053-3a05fe0adea1
|
2
|
Initial serum (1,3)-β-d-glucan as a predictor of mortality in proven candidaemia: findings from a retrospective study in two teaching hospitals in Italy and Brazil, file e268c4ca-3796-a6b7-e053-3a05fe0adea1
|
2
|
History of schistosomiasis (bilharziasis) in humans: from Egyptian medical papyri to molecular biology on mummies, file e268c4ca-6fca-a6b7-e053-3a05fe0adea1
|
2
|
Colistin versus colistin plus meropenem for severe infections, file e268c4ca-719a-a6b7-e053-3a05fe0adea1
|
2
|
Lower sensitivity of serum (1,3)-β-D-glucan for the diagnosis of candidaemia due to Candida parapsilosis, file e268c4ca-777f-a6b7-e053-3a05fe0adea1
|
2
|
Meropenem for treating KPC-producing Klebsiella pneumoniae bloodstream infections: should we get to the PK/PD root of the paradox?, file e268c4ca-855c-a6b7-e053-3a05fe0adea1
|
2
|
Role of fecal microbiota transplantation in inflammatory bowel disease, file e268c4ca-8831-a6b7-e053-3a05fe0adea1
|
2
|
Post-operative abdominal infections: epidemiology, operational definitions, and outcomes, file e268c4cb-72ae-a6b7-e053-3a05fe0adea1
|
2
|
The safety of treatment options for acute bacterial skin and skin structure infections, file e268c4cb-7825-a6b7-e053-3a05fe0adea1
|
2
|
Clinical Experience with Ceftazidime-Avibactam for the Treatment of Infections due to Multidrug-Resistant Gram-Negative Bacteria Other than Carbapenem-Resistant Enterobacterales, file e268c4cc-03a1-a6b7-e053-3a05fe0adea1
|
2
|
A look at clinical trial design for new antimicrobials for the adult population, file e268c4cc-03b1-a6b7-e053-3a05fe0adea1
|
2
|
A brief note on randomized controlled trials and compassionate/off-label use of drugs in the early phases of the COVID-19 pandemic, file e268c4cc-5c47-a6b7-e053-3a05fe0adea1
|
2
|
Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing Enterobacterales Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study), file e268c4cc-8db1-a6b7-e053-3a05fe0adea1
|
2
|
Challenges and research priorities to progress the impact of antimicrobial stewardship, file e268c4cc-a1e4-a6b7-e053-3a05fe0adea1
|
2
|
Distinct phenotypes require distinct respiratory management strategies in severe COVID-19, file e268c4cc-d7da-a6b7-e053-3a05fe0adea1
|
2
|
Neurological Manifestations of Severe SARS-CoV-2 Infection: Potential Mechanisms and Implications of Individualized Mechanical Ventilation Settings, file e268c4cc-d7e1-a6b7-e053-3a05fe0adea1
|
2
|
Measles: An overview of a re-emerging disease in children and immunocompromised patients, file e268c4cd-527f-a6b7-e053-3a05fe0adea1
|
2
|
Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion, file e268c4cd-6b60-a6b7-e053-3a05fe0adea1
|
2
|
Early Effects of Passive Leg-Raising Test, Fluid Challenge, and Norepinephrine on Cerebral Autoregulation and Oxygenation in COVID-19 Critically Ill Patients, file e268c4cd-ca2a-a6b7-e053-3a05fe0adea1
|
2
|
Lung distribution of gas and blood volume in critically ill COVID-19 patients: a quantitative dual-energy computed tomography study, file e268c4cd-e59a-a6b7-e053-3a05fe0adea1
|
2
|
The Role of Dysbiosis in Critically Ill Patients With COVID-19 and Acute Respiratory Distress Syndrome, file e268c4ce-149f-a6b7-e053-3a05fe0adea1
|
2
|
Early administration of bamlanivimab in combination with etesevimab increases the benefits of covid-19 treatment: Real-world experience from the liguria region, file e268c4ce-1cc8-a6b7-e053-3a05fe0adea1
|
2
|
Clinical significance of inflammatory markers of bacterial infection in critically ill patients with COVID-19 after treatment with anti-inflammatory and immunomodulatory drugs: A complex new scenario, file e268c4ce-1cca-a6b7-e053-3a05fe0adea1
|
2
|
The Impact of Carbapenem Resistance on Mortality in Patients With Klebsiella Pneumoniae Bloodstream Infection: An Individual Patient Data Meta-Analysis of 1952 Patients, file e268c4ce-a006-a6b7-e053-3a05fe0adea1
|
2
|
Performance of existing definitions and tests for the diagnosis of invasive fungal diseases other than invasive candidiasis and invasive aspergillosis in critically ill, adult patients: A systematic review with qualitative evidence synthesis, file e268c4ce-cced-a6b7-e053-3a05fe0adea1
|
2
|
Anaerobic bloodstream infections in Italy (ITANAEROBY): A 5-year retrospective nationwide survey, file 065f5a3b-29de-4ba8-b8d0-8334d191c753
|
1
|
Early sclerostin assessment in frail elderly patients with sepsis: insights on short- and long-term mortality prediction, file 4304c960-b99e-4827-9344-c0c45403bd1d
|
1
|
Case report: Sotrovimab, remdesivir and nirmatrelvir/ritonavir combination as salvage treatment option in two immunocompromised patients hospitalized for COVID-19, file 6669ed8d-3dc8-45b3-8b78-8e026fde92fe
|
1
|
Pregnancy outcomes following exposure to efavirenz-based antiretroviral therapy in the Republic of Congo, file e268c4c6-ba2e-a6b7-e053-3a05fe0adea1
|
1
|
Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: Clinical features, therapy and outcome from a multicenter study, file e268c4c9-a132-a6b7-e053-3a05fe0adea1
|
1
|
International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP), file e268c4c9-a30e-a6b7-e053-3a05fe0adea1
|
1
|
Recent advances in the pharmacological management of infections due to multidrug-resistant Gram-negative bacteria, file e268c4c9-acdb-a6b7-e053-3a05fe0adea1
|
1
|
Performance of serum (1,3)-ß-d-glucan screening for the diagnosis of invasive aspergillosis in neutropenic patients with haematological malignancies, file e268c4c9-acdf-a6b7-e053-3a05fe0adea1
|
1
|
Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients with Infections Caused by Klebsiella pneumoniae Carbapenemase-producing K. pneumoniae, file e268c4c9-d01c-a6b7-e053-3a05fe0adea1
|
1
|
Ceftolozane/tazobactam: place in therapy, file e268c4c9-dd6a-a6b7-e053-3a05fe0adea1
|
1
|
Use of 1,3-β-D-glucan in invasive fungal diseases in hematology patients, file e268c4c9-f679-a6b7-e053-3a05fe0adea1
|
1
|
Totale |
2.793 |